Annual Accounts Payable
$7.16 M
+$5.80 M+428.82%
31 March 2024
Summary:
Immunovant annual accounts payable is currently $7.16 million, with the most recent change of +$5.80 million (+428.82%) on 31 March 2024. During the last 3 years, it has risen by +$4.72 million (+194.20%). IMVT annual accounts payable is now -61.59% below its all-time high of $18.63 million, reached on 31 March 2022.IMVT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$20.73 M
+$9.69 M+87.83%
30 September 2024
Summary:
Immunovant quarterly accounts payable is currently $20.73 million, with the most recent change of +$9.69 million (+87.83%) on 30 September 2024. Over the past year, it has increased by +$13.22 million (+175.96%). IMVT quarterly accounts payable is now -21.66% below its all-time high of $26.46 million, reached on 30 June 2023.IMVT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +428.8% | +176.0% |
| 3 y3 years | +194.2% | +388.5% |
| 5 y5 years | - | - |
IMVT Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -61.6% | +428.8% | -21.7% | +1844.4% |
| 5 y | 5 years | -61.6% | +501.3% | -21.7% | +1844.4% |
| alltime | all time | -61.6% | +501.3% | -21.7% | +1844.4% |
Immunovant Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $20.73 M(+87.8%) |
| June 2024 | - | $11.04 M(+54.2%) |
| Mar 2024 | $7.16 M(+428.8%) | $7.16 M(+83.0%) |
| Dec 2023 | - | $3.91 M(-47.9%) |
| Sept 2023 | - | $7.51 M(-71.6%) |
| June 2023 | - | $26.46 M(+1855.6%) |
| Mar 2023 | $1.35 M(-92.7%) | $1.35 M(-90.3%) |
| Dec 2022 | - | $14.00 M(+87.7%) |
| Sept 2022 | - | $7.46 M(+599.9%) |
| June 2022 | - | $1.07 M(-94.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | $18.63 M(+666.0%) | $18.63 M(+386.8%) |
| Dec 2021 | - | $3.83 M(-9.8%) |
| Sept 2021 | - | $4.24 M(+36.6%) |
| June 2021 | - | $3.11 M(+27.8%) |
| Mar 2021 | $2.43 M(+104.4%) | $2.43 M(+15.8%) |
| Dec 2020 | - | $2.10 M(-63.7%) |
| Sept 2020 | - | $5.79 M(-27.8%) |
| June 2020 | - | $8.01 M(+573.2%) |
| Mar 2020 | $1.19 M | $1.19 M(-57.7%) |
| Dec 2019 | - | $2.81 M |
FAQ
- What is Immunovant annual accounts payable?
- What is the all time high annual accounts payable for Immunovant?
- What is Immunovant annual accounts payable year-on-year change?
- What is Immunovant quarterly accounts payable?
- What is the all time high quarterly accounts payable for Immunovant?
- What is Immunovant quarterly accounts payable year-on-year change?
What is Immunovant annual accounts payable?
The current annual accounts payable of IMVT is $7.16 M
What is the all time high annual accounts payable for Immunovant?
Immunovant all-time high annual accounts payable is $18.63 M
What is Immunovant annual accounts payable year-on-year change?
Over the past year, IMVT annual accounts payable has changed by +$5.80 M (+428.82%)
What is Immunovant quarterly accounts payable?
The current quarterly accounts payable of IMVT is $20.73 M
What is the all time high quarterly accounts payable for Immunovant?
Immunovant all-time high quarterly accounts payable is $26.46 M
What is Immunovant quarterly accounts payable year-on-year change?
Over the past year, IMVT quarterly accounts payable has changed by +$13.22 M (+175.96%)